Cancellation Of RFP Upended
Client Alert | less than 1 min read | 08.18.05
In Rand & Jones Enters. Comp., Inc. (Aug. 4, 2005 http://www.gao.gov/decisions/bidpro/296483.htm), GAO held that Veterans Affairs lacked a reasonable basis for canceling an RFP when the cancellation was based on no technical evaluation factors in the RFP and the agency intended to issue an IFB for the same requirement. Both the RFP and IFB would be based on the same evaluation factor (price), no evidence suggested that the government or the integrity of the procurement system would be prejudiced if the RFP were not cancelled, and the low offeror would be prejudiced by recompetition since its low price had previously been disclosed publicly.
Insights
Client Alert | 9 min read | 10.21.26
The life sciences sector is uniquely vulnerable to the inherent risks of AI-generated evidence in drug development and discovery. This client alert focuses on five core challenges: hallucinations, skewed predictions from unrepresentative training data, the opacity of AI reasoning, input sensitivity that undermines reproducibility, and adversarial manipulation of training data. To address these risks, companies should use experimental validation and human oversight as the common legal and regulatory safety net. This entails among other measures auditing AI outputs, characterizing training data, and structural oversight. Companies also should prepare for evolving frameworks and guidance from the U.S. Food and Drug Administration (FDA) and the European Union (EU) that address use of AI in drug discovery and development .
Client Alert | 2 min read | 10.21.26
Client Alert | 3 min read | 10.21.26
Private Investigations Act Series: Temporal, material and territorial scope
Client Alert | 7 min read | 10.21.26
